Maag Peter 4
4 · CareDx, Inc. · Filed Aug 22, 2024
Insider Transaction Report
Form 4
CareDx, Inc.CDNA
Maag Peter
DirectorSee Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-08-20$7.96/sh+26,708$212,596→ 365,576 total - Sale
Common Stock
2024-08-20$33.23/sh−8,844$293,886→ 356,732 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-08-20−26,708→ 2,428 totalExercise: $7.96Exp: 2033-06-16→ Common Stock (26,708 underlying) - Sale
Common Stock
2024-08-20$32.67/sh−12,818$418,764→ 330,024 total - Sale
Common Stock
2024-08-20$33.25/sh−13,890$461,843→ 342,842 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.75, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.345 to $33.000, inclusive.
- [F3]This option was originally granted on June 16, 2023 and, as of June 16, 2024, was fully vested.